Concepedia

Barbara Merelli

BM

Statistics

Publications

32

Citations

1.5K

H-Index

21

Active since

2010

Affiliations

Ospedale Papa Giovanni XXIII(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Oncologico Veneto

University of Turin

Mario Negri Institute for Pharmacological Research

Barbara Merelli is an author at Ospedale Papa Giovanni XXIII specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2010–2025

32

Publications

32

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics

Daniela Massi, Davide Brusa, Barbara Merelli et al. · Annals of Oncology · 2014 · 146 citations · Full text

Medicine, Cancer Biology, Oncology +16

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2024 · 125 citations

Medicine, Clinical Sciences, Oncology +16

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma

Ailin Lepletier, Jason Madore, Jake S. O’Donnell et al. · Clinical Cancer Research · 2020 · 112 citations · Full text

Medicine, Immunology, Oncology +17

The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600

Daniela Massi, Davide Brusa, Barbara Merelli et al. · Annals of Oncology · 2015 · 104 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Vanna Chiarion‐Sileni, Jacopo Pigozzo, Paolo A. Ascierto et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 100 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–5 of 32